Osteonecrosis of the jaw: Long-term follow-up shows variable rate of healing
Min Hu(China Agricultural University), Robert F. Gagel(The University of Texas MD Anderson Cancer Center), Kadri Altundağ(Hacettepe University Hospital), Béla B. Toth(The University of Texas MD Anderson Cancer Center), G. N. Hortobagyi(The University of Texas MD Anderson Cancer Center), Valentina Guarneri(Istituto Oncologico Veneto), Jeffrey Cui(The University of Texas MD Anderson Cancer Center), Ana O. Hoff(Shanghai Jiao Tong University)
Cited by 0
Related Papers
A map of human genome variation from population-scale sequencing
|Nature|2010|8.1k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517